Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

OpGen Announces Strategic Collaboration with IQT

Published: Tuesday, May 01, 2012
Last Updated: Tuesday, May 01, 2012
Bookmark and Share
The collaboration is focused on developing a new high-throughput sequence and genome mapping pipeline for microbial genome analysis.

The technology is being developed for the Department of Homeland Security Science and Technology Directorate (DHS S&T), an IQT customer agency, and the National Bioforensic Analysis Center, a DHS S&T laboratory.

"OpGen is the leader in developing Whole Genome Mapping technologies for use with next generation sequencing (NGS) analysis pipelines," said Simon Davidson, partner on IQT's Investments team. "The company is the ideal partner to develop new software for high performance microbial data analysis to increase the speed and accuracy of analyzing samples from different sources to detect potential bio-threat organisms that may pose a danger to public health."

The enhanced application will automate the generation of OpGen's Whole Genome Maps for use in high-throughput genomic assembly and analysis pipelines. The suite of applications in the pipeline will automatically align DNA sequence data to a map of the entire genome and recommend the most accurate finished sequences derived from the highest confidence alignments. The software system is being developed for use with computer clusters and cloud computing to provide rapid, accurate, reproducible and standardized assembly of microbial genome sequences.

"Combining OpGen's Whole Genome Maps with next-generation sequencing saves finishing cost and time while significantly increasing accuracy," said Richard Moore, M.D., Ph.D., chief scientific officer of OpGen. "The additional automation to be provided by this collaboration will make the finishing process much more efficient. In addition, this project will enable more flexible configuration of the Argus(R) system allowing us to better meet the analysis needs of our customers."

"We are pleased to partner with IQT to develop innovative tools for high-throughput, whole genome, sequence analysis," said Douglas White, chief executive officer of OpGen. "Our ultimate goal is to develop systems, databases and services that simplify and standardize processes and information to enable the broader adoption of next-generation sequencing and Whole Genome Mapping for practical application in the biodefense, public health and clinical markets."


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

OpGen and Hitachi Enter into an Agreement
The companies to develop offering that combines Whole Genome Mapping™ with cloud-based informatics and data management platforms.
Thursday, October 17, 2013
OpGen Assists 100K Genome Project
OpGen, Inc. has entered into a scientific and technical partnership with UC Davis in cooperation with the 100K Genome Project to create high resolution microbial genetic maps.
Thursday, December 20, 2012
OpGen Announces Formation of Public Health Consortium
Consortium to evaluate whole genome mapping for improved genetic analysis of disease outbreaks.
Friday, May 18, 2012
OpGen's Whole Genome Mapping System Features at International Plant & Animal Genome XX Conference
The company announced today that the company's new Whole Genome Mapping and Genome Builder(TM) software was featured in a poster session at the International Plant & Animal Genome XX Conference, January 14-18, 2012 in San Diego.
Tuesday, January 17, 2012
OpGen Strengthens Management Team to Accelerate Commercialization Strategy
Whole genome analysis company appoints new CIO and names key executive positions.
Thursday, December 22, 2011
OpGen Receives Frost & Sullivan New Product Innovation Award
OpGen, Inc. announces the company was chosen to receive the Frost & Sullivan 2011 Best Practice Award for New Product Innovation for their Whole Genome Mapping System.
Wednesday, August 24, 2011
Scientific News
Poor Survival Rates in Leukemia Linked to Persistent Genetic Mutations
For patients with an often-deadly form of leukemia, new research suggests that lingering cancer-related mutations – detected after initial treatment with chemotherapy – are associated with an increased risk of relapse and poor survival.
Searching Big Data Faster
Theoretical analysis could expand applications of accelerated searching in biology, other fields.
Growing Hepatitis C in the Lab
Recent discovery allows study of naturally occurring forms of hepatitis C virus (HCV) in the lab.
Inciting an Immune Attack on Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
Reprogramming Cancer Cells
Researchers on Mayo Clinic’s Florida campus have discovered a way to potentially reprogram cancer cells back to normalcy.
Genetic Overlapping in Multiple Autoimmune Diseases May Suggest Common Therapies
CHOP genomics expert leads analysis of genetic architecture, with eye on repurposing existing drugs.
Surprising Mechanism Behind Antibiotic-Resistant Bacteria Uncovered
Now, scientists at TSRI have discovered that the important human pathogen Staphylococcus aureus, develops resistance to this drug by “switching on” a previously uncharacterized set of genes.
How DNA ‘Proofreader’ Proteins Pick and Edit Their Reading Material
Researchers from North Carolina State University and the University of North Carolina at Chapel Hill have discovered how two important proofreader proteins know where to look for errors during DNA replication and how they work together to signal the body’s repair mechanism.
Fat in the Family?
Study could lead to therapeutics that boost metabolism.
Tissue Bank Pays Dividends for Brain Cancer Research
Checking what’s in the bank – the Brisbane Breast Bank, that is – has paid dividends for UQ cancer researchers.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!